NCT00200577View on ClinicalTrials.gov

Tumor Infiltrating Lymphocytes Adjuvant Therapy of Melanoma

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Melanoma
Interventions
DRUG

TIL + IL2

Patients are treated with 2 injections Of TIL (1st injection M1 and the second M2)The received concomitant IL2 at M1 and M2 on days Jo (injection TIL) to J5 and J8 to J12

Trial Locations (9)

44093

Nantes University Hospital, Nantes

Unknown

CHU Angers, Angers

CHU Caen, Caen

Grenoble University Hospital, Grenoble

CH Le Mans, Le Mans

Montpellier University Hospital, Montpellier

CHU Poitiers, Poitiers

CHU Rennes, Rennes

CHRU Tours, Tours

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT00200577 - Tumor Infiltrating Lymphocytes Adjuvant Therapy of Melanoma | Biotech Hunter | Biotech Hunter